查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553462

高通量筛检市场规模、份额和趋势分析报告：2024-2030 年按产品/服务、技术、应用、最终用途、地区和细分市场进行的预测

High Throughput Screening Market Size, Share & Trends Analysis Report By Product And Services (Consumables), By Technology (Cell-based Assays), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

高通量筛检市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球高通量筛检市场规模预计将达到416.7亿美元，2024年至2030年复合年增长率为10.6%。

製药公司越来越多地采用快速、精确的技术向市场推出新分子，预计将显着提振市场。

高通量筛检用于基于各种基础（包括化学、药物和遗传反应）测试正在开发的分子。这些筛检有助于根据即时结果和模拟分子与身体之间自然反应的近自然条件来设计和开发药物。

此外，该方法可以使用在短时间内储存和处理大量资料的资料储存设备以及能够处理完全自动化流程的必要硬体和软体来完全自动化。

截至 2016 年，大约 55.0% 的高通量筛检测试是基于细胞检测进行的。基于细胞的测定主要由于其在细胞层面上获得的结果以及途径和机製而被使用。

这些测定范围从包括细胞凋亡在内的细胞毒性测试到细胞代谢测定。另一项主要技术的引入是 3D 细胞培养的引入，它有助于模拟自然条件并为所执行的测试提供更准确的结果和反应。预计这一趋势将在预测期内支持市场成长。

高通量筛检市场报告亮点

  • 该市场是由製药公司之间不断增加的引入新分子的竞争所推动的。
  • 即时提供更好结果的 3D 细胞培养技术的出现将推动市场发展。
  • 北美已成为该技术开发和实施的明显热点，占据了相当大的市场份额。
  • 由于需要新分子来治疗各种疾病，预计亚太和拉丁美洲等新兴地区的需求将在预测期内显着增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 高通量筛检(HTS) 市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 高通量筛检(HTS) 市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 高通量筛检(HTS) 市场：依产品/服务进行估算与趋势分析

  • 细分仪表板
  • 高通量筛检(HTS) 市场：2023 年和 2030 年产品与服务波动分析
  • 消耗品
  • 装置
  • 服务
  • 软体

第五章 高通量筛检（HTS）市场：技术估算与趋势分析

  • 细分仪表板
  • 高通量筛检(HTS) 市场：2023 年和 2030 年按技术分類的变异分析
  • 基于细胞的检测
  • 实验室晶片技术 (LOC)
  • 无标定技术
  • 超高通量筛检

第六章 高通量筛检（HTS）市场：依应用进行估算与趋势分析

  • 细分仪表板
  • 高通量筛检(HTS) 市场：2023 年和 2030 年按应用分类的变异分析
  • 药物发现计划
  • 化学生物学项目
  • 生化筛检
  • 基于细胞和器官的筛检

第七章 高通量筛检（HTS）市场：依最终用途进行估算与趋势分析

  • 细分仪表板
  • 高通量筛检(HTS) 市场：2023 年和 2030 年最终用途的变化分析
  • 製药和生物製药公司
  • 学术研究所
  • 受託研究机构（CRO）
  • 其他的

第八章高通量筛检（HTS）市场：区域估计和趋势分析

  • 2023 年及 2030 年高通量筛检(HTS)市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc
    • Aurora Biomed Inc.
    • Tecan Trading AG
    • Promega Corporation
    • Charles River Laboratories.
    • Creative Biolabs.
简介目录
Product Code: GVR-2-68038-155-9

High Throughput Screening Market Growth & Trends:

The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

High Throughput Screening Market Report Highlights:

  • The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
  • Emerging 3D cell culture technology that provides better results in real-time is set to boost the market
  • North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
  • Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. High Throughput Screening (HTS) Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. High Throughput Screening (HTS) Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. High Throughput Screening (HTS) Market: Product and Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. High Throughput Screening (HTS) Market: Product and services Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.3.1.1. Reagents & Assay Kits
        • 4.3.1.1.1. Reagents & Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.3.1.2. Laboratory Equipment
        • 4.3.1.2.1. Laboratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.1. Liquid Handling Systems
        • 4.4.1.1.1. Liquid Handling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.2. Detection Systems
        • 4.4.1.2.1. Detection Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.3. Other Instruments
        • 4.4.1.3.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Software
    • 4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. High Throughput Screening (HTS) Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. High Throughput Screening (HTS) Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Cell-based Assays
    • 5.3.1. Cell-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.1. Fluorometric Imaging Plate Reader Assays
        • 5.3.1.1.1. Fluorometric Imaging Plate Reader Assays Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 5.3.1.1.2. Clinical Applications
          • 5.3.1.1.2.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 5.3.1.1.3. In-vitro Studies
          • 5.3.1.1.3.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.2. Reporter Based Assays
        • 5.3.1.2.1. Clinical Applications
          • 5.3.1.2.1.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 5.3.1.2.2. In-vitro Studies
          • 5.3.1.2.2.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.3. 3D - Cell Cultures
        • 5.3.1.3.1. 3D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 5.3.1.3.2. Scaffold-based Technology
          • 5.3.1.3.2.1. Scaffold-based Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 5.3.1.3.3. Scaffold-free Technology
          • 5.3.1.3.3.1. Scaffold-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.4. 2D - Cell Cultures
        • 5.3.1.4.1. 2D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.5. Reporter-based Assays
        • 5.3.1.5.1. Reporter-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.6. Perfusion Cell Culture
        • 5.3.1.6.1. Perfusion Cell Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Lab-on-a-chip Technology (LOC)
    • 5.4.1. Lab-on-a-chip Technology (LOC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Label-free Technology
    • 5.5.1. Label-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Ultra High Throughput Screening
    • 5.6.1. Ultra High Throughput Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. High Throughput Screening (HTS) Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. High Throughput Screening (HTS) Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Drug Discovery Programs
    • 6.3.1. Drug Discovery Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Chemical Biology Programs
    • 6.4.1. Chemical Biology Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Biochemical Screening
    • 6.5.1. Biochemical Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Cell & Organ-based Screening
    • 6.6.1. Cell & Organ-based Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. High Throughput Screening (HTS) Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. High Throughput Screening (HTS) Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 7.3. Pharmaceutical & Biopharmaceutical Companies
    • 7.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Contract Research Organizations (CROs)
    • 7.5.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. High Throughput Screening (HTS) Market: Regional Estimates & Trend Analysis

  • 8.1. High Throughput Screening (HTS) Market Share, By Region, 2023 & 2030 (USD Billion)
  • 8.2. North America
    • 8.2.1. North America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.3. Canada
      • 8.2.3.1. Canada High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2. U.K.
      • 8.3.2.1. U.K. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3. Germany
      • 8.3.3.1. Germany High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4. France
      • 8.3.4.1. France High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.5. Italy
      • 8.3.5.1. Italy High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.6. Spain
      • 8.3.6.1. Spain High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Norway High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.2. China
      • 8.4.2.1. China High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Japan High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. India High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6. Australia
      • 8.4.6.1. Australia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3. UAE
      • 8.6.3.1. UAE High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Agilent Technologies, Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Danaher Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. PerkinElmer Inc.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bio-Rad Laboratories, Inc
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Aurora Biomed Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Tecan Trading AG
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Promega Corporation
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Charles River Laboratories.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Creative Biolabs.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives